nach oben

Current Oral Health Reports

Erschienen in:

29.01.2020 | Host Parasite Interactions in Periodontal Disease (C Genco and D Kinane, Section Editors)

Persistence of Tannerella forsythia and Fusobacterium nucleatum in Dental Plaque: a Strategic Alliance

verfasst von: Ashu Sharma

Erschienen in: Current Oral Health Reports | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The Gram-negative oral pathogen Tannerella forsythia is implicated in the pathogenesis of periodontitis, an inflammatory disease characterized by progressive destruction of the tooth-supporting structures affecting over 700 million people worldwide. This review highlights the basis of why and how T. forsythia interacts with Fusobacterium nucleatum, a bacterium considered to be a bridge between the early and late colonizing bacteria of the dental plaque.

Recent Findings

The recent findings indicate that these two organisms have a strong mutualistic relationship that involves foraging by T. forsythia on F. nucleatum peptidoglycan and utilization of glucose, released by the hydrolytic activity of T. forsythia glucanase, as a nutrient by F. nucleatum. In addition, T. forsythia has the unique ability to generate a toxic and inflammogenic compound, methylglyoxal, from glucose. This compound can induce inflammation, leading to the degradation of periodontal tissues and release of host components as nutrients for bacteria to further exacerbate the disease.

Summary

In summary, this article will present our current understanding of mechanisms underpinning T. forsythia-F. nucleatum mutualism, and how this mutualism might impact periodontal disease progression.

Sharma A, Sojar HT, Lee JY, Genco RJ. Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics. Infect Immun. 1993;61(8):3570–3.CrossRef

Amano A, Sojar HT, Lee JY, Sharma A, Levine MJ, Genco RJ. Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun. 1994;62(8):3372–80.CrossRef

Nagata H, Sharma A, Sojar HT, Amano A, Levine MJ, Genco RJ. Role of the carboxyl-terminal region of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Infect Immun. 1997;65(2):422–7.CrossRef

Sharma A, Honma K, Sojar HT, Hruby DE, Kuramitsu HK, Genco RJ. Expression of saliva-binding epitopes of the Porphyromonas gingivalis FimA protein on the surface of Streptococcus gordonii. Biochem Biophys Res Commun. 1999;258(1):222–6.CrossRef

Sharma A, Nagata H, Hamada N, Sojar HT, Hruby DE, Kuramitsu HK, et al. Expression of functional Porphyromonas gingivalis fimbrillin polypeptide domains on the surface of Streptococcus gordonii. Appl Environ Microbiol. 1996;62(11):3933–8.CrossRef

Sharma A, Honma K, Evans RT, Hruby DE, Genco RJ. Oral immunization with recombinant Streptococcus gordonii expressing Porphyromonas gingivalis FimA domains. Infect Immun. 2001;69(5):2928–34.CrossRef

Tanner AC, Haffer C, Bratthall GT, Visconti RA, Socransky SS. A study of the bacteria associated with advancing periodontitis in man. J Clin Periodontol. 1979;6(5):278–307.CrossRef

Tanner ACR, Listgarten MA, Ebersole JL, Strzempko MN. Bacteroides forsythus sp. nov., a slow growing, fusiform Bacteroides sp. from the human oral cavity. Int J Syst Bacteriol. 1986;36:213–21.CrossRef

• Wyss C. Dependence of proliferation of Bacteroides forsythus on exogenous N-acetylmuramic acid. Infect Immun. 1989;57(6):1757–9. This study showed that peptidoglycan amino sugar MurNAc is essential for the cultivation of T. forsythia. CrossRef

10.

Sakamoto M, Suzuki M, Umeda M, Ishikawa L, Benno Y. Reclassification of Bacteroides forsythus (Tanner et al. 1986) as Tannerella forsythensis corrig., gen. nov., comb. nov. Int J Syst Evol Microbiol. 2002;52(Pt 3):841–9.PubMed

11.

Warinner C, Rodrigues JF, Vyas R, Trachsel C, Shved N, Grossmann J, et al. Pathogens and host immunity in the ancient human oral cavity. Nat Genet. 2014;46(4):336–44. https://doi.org/10.1038/ng.2906.CrossRef

12.

Booij-Vrieling HE, van der Reijden WA, Houwers DJ, de Wit WE, Bosch-Tijhof CJ, Penning LC, et al. Comparison of periodontal pathogens between cats and their owners. Vet Microbiol. 2010;144:147–52.CrossRef

13.

Oh C, Lee K, Cheong Y, Lee SW, Park SY, Song CS, et al. Comparison of the Oral microbiomes of canines and their owners using next-generation sequencing. PLoS One. 2015;10(7):e0131468. https://doi.org/10.1371/journal.pone.0131468.CrossRef

14.

Beall CJ, Campbell AG, Dayeh DM, Griffen AL, Podar M, Leys EJ. Single cell genomics of uncultured, health-associated Tannerella BU063 (Oral Taxon 286) and comparison to the closely related pathogen Tannerella forsythia. PLoS One. 2014;9(2):e89398. https://doi.org/10.1371/journal.pone.0089398.CrossRefPubMedPubMedCentral

15.

Beall CJ, Campbell AG, Griffen AL, Podar M, Leys EJ. Genomics of the uncultivated, periodontitis-associated bacterium Tannerella sp. BU045 (Oral Taxon 808). mSystems. 2018;3(3). https://doi.org/10.1128/mSystems.00018-18.

16.

Zuger J, Luthi-Schaller H, Gmur R. Uncultivated Tannerella BU045 and BU063 are slim segmented filamentous rods of high prevalence but low abundance in inflammatory disease-associated dental plaques. Microbiology. 2007;153(Pt 11):3809–16. https://doi.org/10.1099/mic.0.2007/010926-0.CrossRefPubMed

17.

Vartoukian SR, Moazzez RV, Paster BJ, Dewhirst FE, Wade WG. First cultivation of health-associated Tannerella sp. HOT-286 (BU063). J Dent Res. 2016;95:1308–13. https://doi.org/10.1177/0022034516651078.CrossRefPubMedPubMedCentral

18.

Camelo-Castillo A, Novoa L, Balsa-Castro C, Blanco J, Mira A, Tomas I. Relationship between periodontitis-associated subgingival microbiota and clinical inflammation by 16S pyrosequencing. J Clin Periodontol. 2015;42(12):1074–82. https://doi.org/10.1111/jcpe.12470.CrossRefPubMed

19.

Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol. 2005;43(8):3944–55.CrossRef

20.

Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–44.CrossRef

21.

Tanner AC, Izard J. Tannerella forsythia, a periodontal pathogen entering the genomic era. Periodontol 2000. 2006;42:88–113. https://doi.org/10.1111/j.1600-0757.2006.00184.x.CrossRefPubMed

22.

Myneni SR, Settem RP, Connell TD, Keegan AD, Gaffen SL, Sharma A. TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J Immunol. 2011;187(1):501–9. https://doi.org/10.4049/jimmunol.1100683.CrossRefPubMedPubMedCentral

23.

Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun. 2007;75(4):1704–12. https://doi.org/10.1128/IAI.00733-06.CrossRef

24.

Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK, et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2011;6:1176. https://doi.org/10.1038/ismej.2011.191.CrossRefPubMedPubMedCentral

25.

Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409–19. https://doi.org/10.1111/j.2041-1014.2012.00663.x.CrossRefPubMedPubMedCentral

26.

Sharma A. Virulence mechanisms of Tannerella forsythia. Periodontol 2000. 2010;54(1):106–16. https://doi.org/10.1111/j.1600-0757.2009.00332.x.CrossRefPubMedPubMedCentral

27.

Honma K, Kuramitsu HK, Genco RJ, Sharma A. Development of a gene inactivation system for Bacteroides forsythus: construction and characterization of a BspA mutant. Infect Immun. 2001;69(7):4686–90.CrossRef

28.

Sharma A. Genome functions of Tannerella forsythia in bacterial communities. In: Kolenbrander PE, editor. Oral Microbial Communities: Genome inquiry and interspecies communication. Washington, D. C.: American Society for Microbiology; 2011. p. 135.

29.

Sharma A, Sojar HT, Glurich I, Honma K, Kuramitsu HK, Genco RJ. Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun. 1998;66(12):5703–10.CrossRef

30.

Stafford G, Roy S, Honma K, Sharma A. Sialic acid, periodontal pathogens and Tannerella forsythia: stick around and enjoy the feast! Mol Oral Microbiol. 2012;27(1):11–22. https://doi.org/10.1111/j.2041-1014.2011.00630.x.CrossRefPubMed

31.

Settem RP, Honma K, Stafford GP, Sharma A. Protein-linked glycans in periodontal bacteria: prevalence and role at the immune interface. Front Microbiol. 2013;4:24146665 (open access). https://doi.org/10.3389/fmicb.2013.00310.CrossRef

32.

Karim AY, Kulczycka M, Kantyka T, Dubin G, Jabaiah A, Daugherty PS, et al. A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037. Biol Chem. 2010;391(1):105–17. https://doi.org/10.1515/BC.2010.009.CrossRefPubMedPubMedCentral

33.

Ksiazek M, Mizgalska D, Eick S, Thogersen IB, Enghild JJ, Potempa J. KLIKK proteases of Tannerella forsythia: putative virulence factors with a unique domain structure. Front Microbiol. 2015;6:312. https://doi.org/10.3389/fmicb.2015.00312.CrossRefPubMedPubMedCentral

34.

Yost S, Duran-Pinedo AE. The contribution of Tannerella forsythia dipeptidyl aminopeptidase IV in the breakdown of collagen. Mol Oral Microbiol. 2018;33(6):407–19. https://doi.org/10.1111/omi.12244.CrossRefPubMedPubMedCentral

35.

Ribeiro AC, Matarazzo F, Faveri M, Zezell DM, Mayer MP. Exploring bacterial diversity of endodontic microbiota by cloning and sequencing 16S rRNA. J Endod. 2011;37(7):922–6. https://doi.org/10.1016/j.joen.2011.04.007.CrossRefPubMed

36.

Rocas IN, Alves FR, Santos AL, Rosado AS, Siqueira JF Jr. Apical root canal microbiota as determined by reverse-capture checkerboard analysis of cryogenically ground root samples from teeth with apical periodontitis. J Endod. 2010;36(10):1617–21. https://doi.org/10.1016/j.joen.2010.07.001. CrossRefPubMed

37.

Brennan RM, Genco RJ, Wilding GE, Hovey KM, Trevisan M, Wactawski-Wende J. Bacterial species in subgingival plaque and oral bone loss in postmenopausal women. J Periodontol. 2007;78(6):1051–61. https://doi.org/10.1902/jop.2007.060436.CrossRefPubMed

38.

Haffajee AD, Socransky SS. Relation of body mass index, periodontitis and Tannerella forsythia. J Clin Periodontolol. 2009;36(2):89–99.CrossRef

39.

Africa CW, Nel J, Stemmet M. Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. Int J Environ Res Public Health. 2014;11(7):6979–7000. https://doi.org/10.3390/ijerph110706979.CrossRefPubMedPubMedCentral

40.

Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77(23):6777–87. https://doi.org/10.1158/0008-5472.CAN-17-1296.CrossRef

41.

Lee HR, Jun HK, Choi BK. Tannerella forsythia BspA increases the risk factors for atherosclerosis in ApoE(-/-) mice. Oral Dis. 2014;20(8):803–8. https://doi.org/10.1111/odi.12214.CrossRefPubMed

42.

Al-Ahmad A, Wunder A, Auschill TM, Follo M, Braun G, Hellwig E, et al. The in vivo dynamics of Streptococcus spp., Actinomyces naeslundii, Fusobacterium nucleatum and Veillonella spp. in dental plaque biofilm as analysed by five-colour multiplex fluorescence in situ hybridization. J Med Microbiol. 2007;56(Pt 5):681–7. https://doi.org/10.1099/jmm.0.47094-0.CrossRefPubMed

43.

Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141–7. https://doi.org/10.1016/j.mib.2014.11.013.CrossRefPubMed

44.

Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/beta-catenin modulator Annexin A1. EMBO Rep. 2019;20(4). https://doi.org/10.15252/embr.201847638.

45.

Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973–80. https://doi.org/10.1136/gutjnl-2015-310101.CrossRef

46.

Sharma A, Inagaki S, Sigurdson W, Kuramitsu HK. Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation. Oral Microbiol Immunol. 2005;20(1):39–42. https://doi.org/10.1111/j.1399-302X.2004.00175.x.CrossRefPubMed

47.

Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmur R, et al. Oral biofilm architecture on natural teeth. PLoS One. 2010;5(2):e9321. https://doi.org/10.1371/journal.pone.0009321.CrossRefPubMedPubMedCentral

48.

Takemoto T, Kurihara H, Dahlen G. Characterization of Bacteroides forsythus isolates. J Clin Microbiol. 1997;35(6):1378–81.CrossRef

49.

Settem RP, El-Hassan AT, Honma K, Stafford GP, Sharma A. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect Immun. 2012;80(7):2436–43. https://doi.org/10.1128/iai.06276-11.CrossRefPubMedPubMedCentral

50.

Park JT. Murein synthesis. In: Neidhardt JL, Ingraham KB, Low B, Magasanik M, Schaechter UHE, editors. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, D. C.: American Society for MIcrobiology; 1987. p. 663–7.

51.

Vollmer W, Seligman SJ. Architecture of peptidoglycan: more data and more models. Trends Microbiol. 18(2):59–66. https://doi.org/10.1016/j.tim.2009.12.004.CrossRef

52.

Ruscitto A, Sharma A. Peptidoglycan synthesis in Tannerella forsythia: scavenging is the modus operandi. Mol Oral Microbiol. 2018;33:125–32. https://doi.org/10.1111/omi.12210.CrossRefPubMedPubMedCentral

53.

Ruscitto A, Hottmann I, Stafford GP, Schaffer C, Mayer C, Sharma A. Identification of a novel N-acetylmuramic acid transporter in Tannerella forsythia. J Bacteriol. 2016;198(22):3119–25. https://doi.org/10.1128/JB.00473-16.CrossRefPubMedPubMedCentral

54.

Ruscitto A, Honma K, Veeramachineni VM, Nishikawa K, Stafford GP, Sharma A. Regulation and molecular basis of environmental muropeptide uptake and utilization in fastidious oral anaerobe Tannerella forsythia. Front Microbiol. 2017;8:648. https://doi.org/10.3389/fmicb.2017.00648.CrossRefPubMedPubMedCentral

55.

•• Honma K, Ruscitto A, Sharma A. beta-Glucanase activity of the oral bacterium Tannerella forsythia contributes to the growth of a partner species, Fusobacterium nucleatum, in cobiofilms. Appl Environ Microbiol. 2018;84(1). https://doi.org/10.1128/AEM.01759-17. This study showed that T. forsythia contact with F. nucleatum leads to the induction of β-glucanse.

56.

Maiden MFJ, Pham C, Kashket S. Glucose toxicity effect and accumulation of methylgloxal by the periodontal pathogen Bacteroides forsythus. Anaerobe. 2004;10:27–32.CrossRef

57.

• Settem RP, Honma K, Shankar M, Li M, LaMonte M, Xu D, et al. Tannerella forsythia produced methylglyoxal causes advanced glycation endproducts (AGEs) accumulation to trigger cytokine secretion in human monocytes. Mol Oral Microbiol. 2018;33:292–9. https://doi.org/10.1111/omi.12224. This study showed that T. forsythia promotes formation of AGEs via production of methylglyoxal. CrossRefPubMedPubMedCentral

58.

Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83(11):876–86. https://doi.org/10.1007/s00109-005-0688-7.CrossRef

59.

Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15(7):16R–28R. https://doi.org/10.1093/glycob/cwi053.CrossRefPubMed

60.

Bertsche U, Mayer C, Gotz F, Gust AA. Peptidoglycan perception--sensing bacteria by their common envelope structure. Int J Med Microbiol. 2015;305(2):217–23. https://doi.org/10.1016/j.ijmm.2014.12.019.CrossRefPubMed

61.

Boneca IG. The role of peptidoglycan in pathogenesis. Curr Opin Microbiol. 2005;8(1):46–53. https://doi.org/10.1016/j.mib.2004.12.008.CrossRefPubMed

62.

McDonald C, Inohara N, Nunez G. Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem. 2005;280(21):20177–80. https://doi.org/10.1074/jbc.R500001200.CrossRefPubMed

63.

Stewart-Tull DE. The immunological activities of bacterial peptidoglycans. Annu Rev Microbiol. 1980;34:311–40. https://doi.org/10.1146/annurev.mi.34.100180.001523.CrossRefPubMed

64.

Caruso R, Warner N, Inohara N, Nunez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41(6):898–908. https://doi.org/10.1016/j.immuni.2014.12.010.CrossRefPubMedPubMedCentral

65.

Nigro G, Fazio LL, Martino MC, Rossi G, Tattoli I, Liparoti V, et al. Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell Microbiol. 2008;10(3):682–95. https://doi.org/10.1111/j.1462-5822.2007.01075.x.CrossRef

66.

Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006;7(12):1250–7. https://doi.org/10.1038/ni1412.CrossRefPubMed

67.

Radford-Smith G, Pandeya N. Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease--are we there yet? World J Gastroenterol. 2006;12(44):7097–103.CrossRef

68.

Kim TH, Payne U, Zhang X, Iwanaga Y, Davey MP, Rosenbaum JT, et al. Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2. Rheumatol Int. 2007;27(3):257–62. https://doi.org/10.1007/s00296-006-0250-0.CrossRef

69.

Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003;100(6):3455–60. https://doi.org/10.1073/pnas.0530276100.CrossRef

70.

Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol. 2003;4(7):702–7. https://doi.org/10.1038/ni945.CrossRef

71.

Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 2003;278(43):41702–8. https://doi.org/10.1074/jbc.M307198200.CrossRefPubMed

72.

Kashket S, Maiden MF, Haffajee AD, Kashket ER. Accumulation of methylglyoxal in the gingival crevicular fluid of chronic periodontitis patients. J Clin Periodontol. 2003;30(4):364–7.CrossRef

73.

Retamal IN, Hernandez R, Gonzalez-Rivas C, Caceres M, Arancibia R, Romero A, et al. Methylglyoxal and methylglyoxal-modified collagen as inducers of cellular injury in gingival connective tissue cells. J Periodontal Res. 2016;51(6):812–21.CrossRef

Titel: Persistence of Tannerella forsythia and Fusobacterium nucleatum in Dental Plaque: a Strategic Alliance
verfasst von: Ashu Sharma
Publikationsdatum: 29.01.2020
Verlag: Springer International Publishing
Erschienen in: Current Oral Health Reports / Ausgabe 1/2020
Elektronische ISSN: 2196-3002
DOI: https://doi.org/10.1007/s40496-020-00254-6

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Springer Medizin

Persistence of Tannerella forsythia and Fusobacterium nucleatum in Dental Plaque: a Strategic Alliance

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

The Buffalo OsteoPerio Studies: Summary of Our Findings and the Unique Contributions of Robert J. Genco, DDS, PhD

Could Vitamin D Influence Risk for Periodontal Disease—to “D” or Not to “D”?

Periodontitis: a Host-Mediated Disruption of Microbial Homeostasis

From Periodontitis to Periimplantitis—the Quest for the Missing Link

Periodontal Disease and Systemic Interactions (Periodontal Medicine): Current Epidemiological Evidence

On the Role of Mentorship in Team Science

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter